The U.S. FDA has approved an expanded indication for Sanofi (NASDAQ:SNY)’s quadrivalent meningococcal vaccine, MenQuadfi, now allowing its use in children as young as 6 weeks old. Previously approved ...

The U.S. Food and Drug Administration (FDA) has approved Sanofi’s (NASDAQ:SNY) meningococcal vaccine MenQuadfi for infants as young as six weeks, expanding its previous label indicated for children ...

FDA approves MenQuadfi TM, the latest innovation in meningococcal (MenACWY) vaccination Latest innovation in quadrivalent meningococcal vaccination designed for use in persons 2 years of age and older ...

The FDA has approved expanded use of Sanofi Pasteur’s MenQuadfi, a meningococcal conjugate vaccine for children aged 2 to 10. MenQuadfi is now the first quadrivalent conjugate vaccine licensed in the ...

Tiffani Thiessen, an actress best known for her roles on Beverly Hills 90210 and Saved by the Bell, is serving as a spokesperson for National Meningitis Association’s new vaccine effort. It’s About ...

Latest innovation in quadrivalent meningococcal vaccination designed for use in persons 2 years of age and older in the U.S. Safety and effectiveness studied in five double-blind, randomized clinical ...